blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2104488

EP2104488 - GAS-FILLED MICROVESICLES COMPRISING THE FC-REGION OF AN ANTIBODY [Right-click to bookmark this link]
Former [2009/40]GAS-FILLED MICROVESICLES WITH TARGETING LIGAND IN RESPECT OF FC-REGION OF AN ANTIBODY OR THERAPEUTIC AGENT
[2016/22]
StatusNo opposition filed within time limit
Status updated on  18.08.2017
Database last updated on 04.11.2024
Most recent event   Tooltip21.09.2018Lapse of the patent in a contracting state
New state(s): MT		published on 24.10.2018  [2018/43]
Applicant(s)For all designated states
Bracco Suisse SA
Centro Galleria
Via Cantonale 2
6928 Manno / CH
[2016/41]
Former [2012/04]For all designated states
Bracco Suisse S.A.
Centro Galleria 2
Via Cantonale
6928 Manno / CH
Former [2009/40]For all designated states
Bracco Research SA
Route de la Galaise 31
1228 Plan-Les-Ouates / CH
Inventor(s)01 / ALLEMANN, Eric
Bracco Research SA
31 Route de la Galaise
1228 Plan-les-Ouates / CH
02 / BETTINGER, Thierry
Bracco Research SA
31 Route de la Galaise
1228 Plan-les-ouates / CH
03 / BUSSAT, Philippe
Bracco Research SA
31 Route de la Galaise
1228 Plan-les-Ouates / CH
 [2016/41]
Former [2009/40]01 / ALLEMANN, Eric
Bracco Research SA 31 Route de la Galaise
1228 Plan-les-Ouates / CH
02 / BETTINGER, Thierry
Bracco Research SA 31 Route de la Galaise
1228 Plan-les-ouates / CH
03 / BUSSAT, Philippe
Bracco Research SA 31 Route de la Galaise
1228 Plan-les-Ouates / CH
Representative(s)Ravizza, Claudio
Bracco Suisse S.A.
Intellectual Property Department
31, route de la Galaise
1228 Plan-les-Ouates / CH
[2012/04]
Former [2009/40]Ravizza, Claudio
Bracco Research SA, 31, route de la Galaise
1258 Plan-les-Ouates / CH
Application number, filing date07859130.219.12.2007
[2009/40]
WO2007IB04017
Priority number, dateUS2006064128919.12.2006         Original published format: US 641289
[2009/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008075191
Date:26.06.2008
Language:EN
[2008/26]
Type: A2 Application without search report 
No.:EP2104488
Date:30.09.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 26.06.2008 takes the place of the publication of the European patent application.
[2009/40]
Type: B1 Patent specification 
No.:EP2104488
Date:12.10.2016
Language:EN
[2016/41]
Search report(s)International search report - published on:EP27.11.2008
ClassificationIPC:A61K39/00, A61K47/00, A61K9/127, A61K49/22
[2016/20]
CPC:
A61K49/223 (EP,US); A61P43/00 (EP)
Former IPC [2009/40]A61K9/00, A61K47/00, A61K39/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/41]
Former [2009/40]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:MIT GAS GEFÜLLTE MIKROVESIKEL ENTHALTEND DIE FC-REGION EINES ANTIKÖRPERS[2016/22]
English:GAS-FILLED MICROVESICLES COMPRISING THE FC-REGION OF AN ANTIBODY[2016/22]
French:MICROVÉSICULES REMPLIÉES AVEC GAZ CONTENANT LA RÉGION FC D'UN ANTICORPS[2016/22]
Former [2009/40]GASGEFÜLLTE MIKROVESIKEL MIT TARGETING-LIGAND FÜR DIE FC-REGION EINES ANTIKÖRPERS ODER THERAPEUTISCHEN MITTELS
Former [2009/40]GAS-FILLED MICROVESICLES WITH TARGETING LIGAND IN RESPECT OF FC-REGION OF AN ANTIBODY OR THERAPEUTIC AGENT
Former [2009/40]MICROVÉSICULES REMPLIES DE GAZ RENFERMANT UN LIGAND DE CIBLAGE OU UN AGENT THÉRAPEUTIQUE
Entry into regional phase09.07.2009National basic fee paid 
09.07.2009Designation fee(s) paid 
09.07.2009Examination fee paid 
Examination procedure09.07.2009Examination requested  [2009/40]
13.12.2010Despatch of a communication from the examining division (Time limit: M04)
19.04.2011Reply to a communication from the examining division
06.05.2016Communication of intention to grant the patent
30.08.2016Fee for grant paid
30.08.2016Fee for publishing/printing paid
30.08.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.12.2010
Opposition(s)13.07.2017No opposition filed within time limit [2017/38]
Fees paidRenewal fee
28.12.2009Renewal fee patent year 03
27.12.2010Renewal fee patent year 04
27.12.2011Renewal fee patent year 05
26.12.2012Renewal fee patent year 06
27.12.2013Renewal fee patent year 07
29.12.2014Renewal fee patent year 08
28.12.2015Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.12.2007
AT12.10.2016
BE12.10.2016
CY12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
TR12.10.2016
IE19.12.2016
LU19.12.2016
MT19.12.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
PT13.02.2017
[2018/43]
Former [2018/29]HU19.12.2007
AT12.10.2016
BE12.10.2016
CY12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
TR12.10.2016
IE19.12.2016
LU19.12.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2018/28]HU19.12.2007
AT12.10.2016
BE12.10.2016
CY12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
IE19.12.2016
LU19.12.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/49]AT12.10.2016
BE12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SI12.10.2016
SK12.10.2016
IE19.12.2016
LU19.12.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/42]AT12.10.2016
BE12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
MC12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/38]AT12.10.2016
BE12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SK12.10.2016
BG12.01.2017
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/36]AT12.10.2016
BE12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
SK12.10.2016
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/35]AT12.10.2016
BE12.10.2016
CZ12.10.2016
DK12.10.2016
EE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
NL12.10.2016
PL12.10.2016
RO12.10.2016
SE12.10.2016
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/34]AT12.10.2016
BE12.10.2016
CZ12.10.2016
DK12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
NL12.10.2016
PL12.10.2016
SE12.10.2016
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/33]AT12.10.2016
BE12.10.2016
DK12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
NL12.10.2016
PL12.10.2016
SE12.10.2016
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/26]AT12.10.2016
BE12.10.2016
ES12.10.2016
FI12.10.2016
LT12.10.2016
LV12.10.2016
NL12.10.2016
PL12.10.2016
SE12.10.2016
GR13.01.2017
IS12.02.2017
PT13.02.2017
Former [2017/12]LV12.10.2016
Cited inInternational search[X]WO03074566  (IMMUNOMEDICS INC [US], et al) [X] 1-19 * claims 24, 72 *;
 [Y]WO9913918  (UNIV PITTSBURGH [US]) [Y] 1-19 * Examples, esp. example 2; claims 2, 8 *;
 [Y]EP1714642  (BRACCO RESEARCH SA [CH]) [Y] 1-19 * claims *;
 [Y]WO2005012493  (IMMUNOMEDICS INC [US], et al) [Y] 1-19 * claims, page 28/29 *;
 [Y]US6630140  (GRUNSTEIN MICHAEL M [US], et al) [Y] 1-19 * claims, examples *;
 [Y]US2005070693  (HANSEN HANS J [US], et al) [Y] 1-19 * claims *;
 [A]WO9640285  (IMARX PHARMACEUTICAL CORP [US], et al) [A] 1-19 * claims *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.